DE69834213D1 - Verfahren zur Überwachung einer osmotischen Wirkstoffabgabevorrichtung - Google Patents

Verfahren zur Überwachung einer osmotischen Wirkstoffabgabevorrichtung

Info

Publication number
DE69834213D1
DE69834213D1 DE69834213T DE69834213T DE69834213D1 DE 69834213 D1 DE69834213 D1 DE 69834213D1 DE 69834213 T DE69834213 T DE 69834213T DE 69834213 T DE69834213 T DE 69834213T DE 69834213 D1 DE69834213 D1 DE 69834213D1
Authority
DE
Germany
Prior art keywords
monitoring
delivery device
drug delivery
osmotic drug
osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834213T
Other languages
English (en)
Other versions
DE69834213T2 (de
Inventor
Rupal Ayer
D Jordan
R Stewart
Stephen Berry
B Eckenhoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69834213D1 publication Critical patent/DE69834213D1/de
Application granted granted Critical
Publication of DE69834213T2 publication Critical patent/DE69834213T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14212—Pumping with an aspiration and an expulsion action
    • A61M5/1424—Manually operated pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2250/00—Specially adapted for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/1684—Monitoring, detecting, signalling or eliminating infusion flow anomalies by detecting the amount of infusate remaining, e.g. signalling end of infusion
DE69834213T 1997-12-31 1998-12-21 Osmotisches Abgabesystem für ein nützliches Mittel Expired - Lifetime DE69834213T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7017897P 1997-12-31 1997-12-31
US70178P 1997-12-31

Publications (2)

Publication Number Publication Date
DE69834213D1 true DE69834213D1 (de) 2006-05-24
DE69834213T2 DE69834213T2 (de) 2007-01-25

Family

ID=22093633

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69834213T Expired - Lifetime DE69834213T2 (de) 1997-12-31 1998-12-21 Osmotisches Abgabesystem für ein nützliches Mittel
DE69817621T Expired - Lifetime DE69817621T2 (de) 1997-12-31 1998-12-21 Osmotisches Abgabesystem für ein wirksames Mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69817621T Expired - Lifetime DE69817621T2 (de) 1997-12-31 1998-12-21 Osmotisches Abgabesystem für ein wirksames Mittel

Country Status (14)

Country Link
US (1) US6283953B1 (de)
EP (1) EP1051217B8 (de)
AR (1) AR014231A1 (de)
AT (2) ATE248002T1 (de)
AU (1) AU1937099A (de)
CA (1) CA2316887C (de)
DE (2) DE69834213T2 (de)
DK (1) DK1051217T3 (de)
ES (1) ES2205595T3 (de)
HK (1) HK1032363A1 (de)
PT (1) PT1051217E (de)
TW (1) TW381974B (de)
WO (1) WO1999033513A1 (de)
ZA (1) ZA9811879B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234603T1 (de) 1998-12-31 2003-04-15 Alza Corp Osmotisches verabreichungsystem mit raumsparenden kolben
CA2390261C (en) * 1999-11-08 2014-04-22 University Of Florida Research Foundation, Inc. Marker detection method and apparatus to monitor drug compliance
US7104963B2 (en) * 2002-01-22 2006-09-12 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring intravenous (IV) drug concentration using exhaled breath
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
US6981947B2 (en) * 2002-01-22 2006-01-03 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring respiratory gases during anesthesia
US20070167853A1 (en) 2002-01-22 2007-07-19 Melker Richard J System and method for monitoring health using exhaled breath
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
CA2477923C (en) 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
MXPA05000232A (es) * 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP2339328A3 (de) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
AU2003272270A1 (en) 2003-02-28 2004-09-28 The Regents Of The University Of Michigan Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US20040214893A1 (en) * 2003-04-11 2004-10-28 Matthew Peterson Gabapentin compositions
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
US20050020899A1 (en) * 2003-07-25 2005-01-27 Rubicor Medical, Inc. Post-biopsy cavity treatmetn implants and methods
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
CA2540056C (en) * 2003-09-26 2015-03-24 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
CA2540059C (en) 2003-09-26 2013-08-06 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
EP2428516A1 (de) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Neue Phosphor enthaltende Thyromimetika
WO2005092065A2 (en) * 2004-03-25 2005-10-06 Transform Pharmaceuticals, Inc. Novel tricyclic compounds and related methods of treatment
JP5017103B2 (ja) * 2004-06-17 2012-09-05 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 薬剤共結晶組成物および関連した使用方法
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
DE102006021016A1 (de) * 2006-05-05 2007-11-15 Dürschinger, Günter Chemisch aktivierbare Kapsel für die Durchgangsprüfung und Behandlung des Darm-Trakts
EP2037999B1 (de) 2006-07-07 2016-12-28 Proteus Digital Health, Inc. Intelligentes parenterales verabreichungssystem
US7914460B2 (en) 2006-08-15 2011-03-29 University Of Florida Research Foundation, Inc. Condensate glucose analyzer
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
KR20180099916A (ko) 2007-02-09 2018-09-05 메타베이시스 테라퓨틱스, 인크. 글루카곤 수용체의 길항제
CA2695583A1 (en) 2007-08-13 2009-02-19 Metabasis Therapeutics, Inc. Novel activators of glucokinase
US8789536B2 (en) * 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8038659B2 (en) * 2007-10-17 2011-10-18 The Invention Science Fund I, Llc Disintegrating digestive tract interaction system
US8303573B2 (en) * 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
JP5243548B2 (ja) 2007-10-25 2013-07-24 プロテウス デジタル ヘルス， インコーポレイテッド 情報システムのための流体伝達ポート
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
EP3153501B1 (de) 2008-08-13 2018-11-28 Metabasis Therapeutics, Inc. Glucagon-antagonisten
MY169700A (en) 2010-02-01 2019-05-13 Proteus Digital Health Inc Data gathering system
BR112012019212A2 (pt) 2010-02-01 2017-06-13 Proteus Digital Health Inc sistema de coleta de dados
AU2011237592B2 (en) 2010-04-08 2016-10-27 Emory University Substituted androst-4-ene diones
WO2012129237A2 (en) 2011-03-20 2012-09-27 Trustees Of Boston University Therapeutic agent for emphysema and copd
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2869870B1 (de) * 2012-07-06 2018-11-14 Sanofi-Aventis Deutschland GmbH Arzneimittelabgabevorrichtung
RS60847B1 (sr) * 2013-08-19 2020-10-30 Taris Biomedical Llc Uređaji za davanje više jedinica leka
WO2015027146A1 (en) 2013-08-22 2015-02-26 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
WO2015191900A1 (en) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
JP7167336B2 (ja) 2018-11-02 2022-11-08 バイオナット ラブス リミテッド 小型化されたデバイスからのペイロード放出の磁気機械的トリガー
WO2023181997A1 (ja) * 2022-03-25 2023-09-28 テルモ株式会社 持続投与装置

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732865A (en) 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3995632A (en) 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
DE2626348C3 (de) * 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4203439A (en) 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4243030A (en) 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4457752A (en) * 1982-09-13 1984-07-03 Csaba Vadasz Surgically implantable pump
US4552561A (en) 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
USH150H (en) 1984-08-03 1986-11-04 Medtronic, Inc. Accessory module for implantable fluid dispensing device
DE3610825A1 (de) * 1985-01-07 1987-10-08 Kurt Dr Ing Ziesche Geraet zur soforthilfe bei herzanfaellen und aehnlichem
NO165378C (no) * 1985-11-22 1991-02-06 Ellingsen O & Co Medikamentavgivende innretning for implantering i menneskekroppen.
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
JPS63300774A (ja) * 1987-05-29 1988-12-07 Kanji Takada 埋込み用薬液注入装置
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
WO1994012159A1 (en) * 1992-11-30 1994-06-09 Pfizer Inc. Supported liquid membrane delivery devices
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
SE9400821D0 (sv) * 1994-03-10 1994-03-10 Siemens Elema Ab Implanterbart infusionssystem med tryckneutral läkemedelsbehållare
CZ293808B6 (cs) 1996-02-02 2004-08-18 Alzaácorporation Implantabilní zařízení k dodávání leuprolidu do okolního tekutinového prostředí
EP0904118B1 (de) * 1996-05-24 2004-07-28 ALZA Corporation System zur beifügung eines nahrungsmittelzusatzes

Also Published As

Publication number Publication date
ATE248002T1 (de) 2003-09-15
HK1032363A1 (en) 2001-07-20
DE69817621T2 (de) 2004-03-25
AR014231A1 (es) 2001-02-07
ZA9811879B (en) 1999-09-02
EP1051217B1 (de) 2003-08-27
CA2316887A1 (en) 1999-07-08
AU1937099A (en) 1999-07-19
ATE322928T1 (de) 2006-04-15
DE69834213T2 (de) 2007-01-25
TW381974B (en) 2000-02-11
EP1051217A1 (de) 2000-11-15
ES2205595T3 (es) 2004-05-01
DE69817621D1 (de) 2003-10-02
US6283953B1 (en) 2001-09-04
DK1051217T3 (da) 2003-12-08
WO1999033513A1 (en) 1999-07-08
PT1051217E (pt) 2003-12-31
CA2316887C (en) 2008-04-08
EP1051217B8 (de) 2004-07-21

Similar Documents

Publication Publication Date Title
DE69834213D1 (de) Verfahren zur Überwachung einer osmotischen Wirkstoffabgabevorrichtung
DE69532840D1 (de) Vorrichtung zur automatischen Selbstinjektion
ATE276866T1 (de) Vorrichtung zur spritzenanfertigung
DE60034415D1 (de) System und Verfahren zur Identifizierung der Anschlussbeziehungen
DE59806967D1 (de) Vorrichtung zur Ultrafiltration bei der Hämodialyse
DE69835292D1 (de) Vorrichtung zur detektierung einer arzneimittel abgabe
DE69835314D1 (de) Verfahren und Vorrichtung zur formatgesteuerten Interaktion zwischen Geräten
DE69937839D1 (de) Vorrichtung und verfahren zur lokalisierung einer kodiereinheit
DE69628344D1 (de) Vorrichtung zur Verabreichung einer Substanz
DE59813553D1 (de) Verfahren und Vorrichtung zur Überprüfung einer Bremsanlage
DE69801106T2 (de) Verfahren und vorrichtung zur niederdruckzerstäubung
ATE301377T1 (de) Verfahren und vorrichtung zur ablauffolgeplanung der rückwärtsverbindungsrate
DE69838618D1 (de) Verfahren zur anzeige einer empfangenen nachricht
DE69922076D1 (de) Vorrichtung zur Feststellung einer Hinweisposition, Anzeigesystem und Verfahren
DE69824545D1 (de) Vorrichtung zur abgabe von kabelbindern
ATE478535T1 (de) Verfahren und vorrichtung zur unterdrückung der anfrage für eine rufinitialisierung
DE69727395D1 (de) Verfahren zur olefinisomerisierung
DE69506406D1 (de) Verfahren zur automatischen begleitung
DE69723817D1 (de) Verfahren und system zur abgabe einer viskösen lösung
DE60110732D1 (de) Verfahren und System zur Überwachung von Frachtauslieferung
DE60035738D1 (de) Verfahren und Vorrichtung zur Charakterisierung optischer Systeme
DE60133478D1 (de) Verfahren und vorrichtung zur versorgung von spritzeinrichtungen und spritzanlage mit einer solchen vorrichtung
DE59810368D1 (de) Verfahren und vorrichtung zur in-situ-formulierung einer arzneistofflösung zur parenteralen applikation
DE69837952D1 (de) Verfahren zur Verwaltung von Fernmeldeleitungen
DE59608890D1 (de) Verfahren zur ansteuerung einer belichtungsvorrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition